Harwin Peter Evan 4
4 · Cogent Biosciences, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
Harwin Peter Evan
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+30,700→ 30,700 totalExercise: $4.59Exp: 2032-06-07→ Common Stock (30,700 underlying)
Footnotes (1)
- [F1]This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.